Swiss drug maker Novartis AG reported Tuesday a 42 percent decline in its third-quarter net profit, reflecting one-time items and the weakness in net sales. Looking ahead, the company confirmed its outlook 2015 for growth in net sales and Core operating income at constant currencies.